Answers are grounded in this paper and cite their sources.
CAP has decreased value for the initial screening of moderate-severe steatosis and is limited in monitoring changes in steatosis during treatment. The confirmation of steatosis grading with MRI-PDFF remains necessary.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: